RNA-seq of human iCell microglia treated with IFN-β for 6 and 24 h
Ontology highlight
ABSTRACT: iCell human microglia were treated in triplicate (replicates a, b and c) with vehicle or 5 ng/mL human IFN-β for 6 or 24 h followed by RNA-sequencing (RNA-seq). The sample preparation, RNA-seq and transcriptomics data analysis were performed by AstraZeneca. The raw FASTQ data files cannot be made publicly available in accordance with the UK General Data Protection Regulation and the Data Protection Act 2018.
INSTRUMENT(S): n/a, RNAdvance Cell v2, Biomek i7 Hybrid robotic workstation (both BeckmanCoulter), KAPA mRNA HyperPrep Kit (Roche), SS NGS fragment kit (1-6,000 bp; Agilent), Illumina NovaSeq 6000
ORGANISM(S): Homo sapiens
SUBMITTER: Svetlana Khoronenkova
PROVIDER: E-MTAB-13404 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA